ARTICLE | Distillery Therapeutics
Therapeutics: An undetermined target
June 25, 2015 7:00 AM UTC
In vitro and mouse studies identified a synthetic variant of the bacterial enzyme lysostaphin that could treat methicillin-resistant Staphylococcus aureus (MRSA) infection with lower immunogenicity th...